DEI Policies in Medicine Face Legal Challenges

The push against DEI in medicine is significantly shaped by the physician-led group Do No Harm, which has filed numerous civil rights complaints against medical schools, alleging that their DEI initiatives lead to illegal racial and gender discrimination. These efforts have reportedly prompted dozens of federal investigations and have led some medical schools to abandon certain DEI-driven practices. The organization is also actively working with lawmakers in over a dozen states to eliminate DEI policies from public medical schools. At the core of the debate are the accreditation standards set by the Liaison Committee on Medical Education (LCME), the sole accrediting body for M.D.-granting medical schools in the U.S. and Canada. LCME standards require schools to have policies and programs for the recruitment and retention of a diverse student body and faculty. Critics argue these standards compel schools to engage in what they deem unlawful discrimination to maintain accreditation. This has led to direct challenges, including a recent executive order targeting the LCME and the Accreditation Council for Graduate Medical Education (ACGME). The order threatens to revoke federal recognition for accrediting bodies that require or promote DEI initiatives, framing them as a distraction from a sole focus on academic rigor. The Association of American Medical Colleges (AAMC) has been a primary driver of DEI initiatives, developing competencies that infuse themes of intersectionality, white privilege, and microaggressions into medical education curricula. The AAMC, which co-sponsors the LCME, has remained steadfast in its commitment to DEI, arguing these efforts are critical for preparing physicians to serve a diverse population and to address health inequities. Legal challenges extend beyond accreditation bodies. Do No Harm has also sued several universities directly, including the University of Washington and the University of Colorado, over specific programs and scholarships aimed at underrepresented minorities. Another significant lawsuit targets UCLA's David Geffen School of Medicine, alleging that its admissions process engages in impermissible racial balancing, a violation of the Fourteenth Amendment and the Civil Rights Act. Proponents of DEI in medicine argue that it is not about a political agenda but is grounded in the science of health disparities and is essential for improving patient outcomes. They contend that a diverse healthcare workforce leads to better patient experiences and helps to reduce health care spending. The American Medical Association has also affirmed its support, advocating for resources to maintain DEI offices in medical schools and opposing actions that would limit such initiatives. As of early 2024, the legislative landscape has become a key battleground, with at least 12 states passing laws that restrict DEI efforts in higher education in some capacity. In Florida, for example, a law now bans public universities from using state or federal funds for DEI programs and restricts what can be taught in general education courses regarding "identity politics." These state-level actions add another layer of complexity for medical schools navigating federal accreditation standards and legal challenges.